Clinical trial

Safety and Acceptability of Carraguard™ Among HIV-negative Couples in Thailand

NCT00213057 · Population Council, Other · Completed

Key facts

NCT number NCT00213057
Title Safety and Acceptability of Carraguard™ Among HIV-negative Couples in Thailand
Official title A Randomized, Placebo-controlled, Double-blind Trial to Assess Expanded Safety and Acceptability of Carraguard™ (PC-515) Vaginal Gel Among Heterosexual Couples in Chiang Rai
Lead sponsor Population Council, Other
Collaborators Centers for Disease Control and Prevention U.S. Fed Ministry of Health, Thailand Chiang Rai Public Health Office Chiang Rai District Health Office Chiang Rai Municipal Health Office Chiang Rai…
Status Completed
Phase Phase 1
Study type Interventional
Conditions HIV Infections, Chlamydia Trachomatis, Nesseria Gonorrhea, Trichomonas Vaginitis, Syphilis
Intervention type Drug
Interventions Carraguard (PC-515)
Enrollment 110
Start date Jun 1, 2001
Completion Jun 1, 2002
First posted Sep 21, 2005
Last update posted Aug 14, 2017
Countries Thailand

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies